PHT180 Research Vitals with Dr André Hudson
Networking event showcasing healthcare technology research topics from internal and external researchers looking for collaborators for new research initiatives.
Antibiotic Resistance: The Good, the Bad and the Ugly
Abstract: Approximately 2.8M people are infected with bacteria that are deemed resistant to clinically relevant antibiotics worldwide, which accounts for 35,000 and 700,000 deaths in the United States respectively. In the 2019 report, The World Health Organization states that if no action is taken, drug resistant diseases could cause 10 million deaths each year by 2050 and that by 2030, antimicrobial resistance could force up to 24 million people into extreme poverty. There is an urgent need for the development of novel antibiotics to combat the drastic rise in the number of antibiotic resistant bacteria.
Bio: Dr. Hudson was born on the island of Jamaica and came to the United States at the age of 14. He completed High School in New Rochelle, NY, received a B.S. in Biology from Virginia Union University (VUU) in 2000 and completed his PhD in the department of Plant Biology and Pathology in 2006 at Rutgers University. He joined the faculty in the RIT Thomas H. Gosnell School of Life Sciences in the Fall of 2008 following a post-doctoral fellowship at Rutgers. Dr. Hudson’s research interests include antibiotic resistance, amino acid metabolism and microbial genomics. He is a dedicated professor and mentor to the next generation of scientists solving today’s problems and solving emerging scientific problems. Dr. Hudson is current serving as interim Dean of the RIT College of Science and was recently elected to the position of Operations Officer for RIT’s faculty senate.
Registration is not required to attend. If you need an interpreter, please contact Gina Lamanna.
Event Snapshot
When and Where
Who
Open to the Public
Interpreter Requested?
No